Special Issue "Nanozymes for Anti-cancer and Anti-bacterial Treatment"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".

Deadline for manuscript submissions: closed (30 May 2023) | Viewed by 111

Special Issue Editors

Division of Chemistry and Biological Chemistry, School of Physical and Mathematical Sciences, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore
Interests: polymeric nanoparticles; drug delivery; biosensing/bioimaging; cancer therapy; bacterial infection
Special Issues, Collections and Topics in MDPI journals
School of Engineering, Brown University, Providence, RI 02912, USA
Interests: materials chemistry; cancer theranostics; nanomedicine

Special Issue Information

Dear Colleagues,

Natural enzymes are biocatalysts that mediate various reactions in biological processes such as signal transduction, metabolism, and digestion. In addition to their important roles in living organisms, enzymes are applicable in the industry due to their high specificity and efficiency. Nevertheless, the widespread application of enzymes is severely hampered by several limitations, including high production cost, ease of denaturation and inactivation, and low yield. As an emerging artificial enzyme, nanozymes that combine the characteristics of nanomaterials and enzymes are promising alternatives. On the one hand, nanozymes possess high enzyme-like catalytic activities to regulate biochemical reactions. On the other hand, nanozymes also inherit the properties of nanomaterials, which can ameliorate the shortcomings of natural enzymes and serve as versatile platforms for diverse applications.

The present Special Issue aims to collect recent research in the design and preparation of nanozymes and focuses on the use of nanozymes in biomedical fields, especially for anti-cancer and anti-bacterial treatment.

Dr. Xiaodong Zhang
Dr. Deblin Jana
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • nanozymes
  • drug delivery
  • nanomedicine
  • bioimaging
  • therapy
  • anti-cancer treatment
  • anti-bacterial treatment

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop